Homebiotech

biotech

biotech

Base to Base biotech podcast 56: GRIN genes and relapsing MS

Jim Cornall - April 24, 2026

biotech

Positive first-in-human data for IVF-related embryo implantation failure treatment

Jim Cornall - April 23, 2026

biotech

New company plans to replace daily injections with implant

Jim Cornall - April 23, 2026

biotech

UCB adds epilepsy drug through Neurona Therapeutics acquisition

Jim Cornall - April 23, 2026

biotech

New nanosensors make diagnostic procedures more sensitive

Jim Cornall - February 15, 2024

biotech

Watch: PhaseV at Bio-Europe

Jim Cornall - January 11, 2024

biotech

DeepMirror launches molecular drug design software

Jim Cornall - December 12, 2023

biotech

Video: Lithuanian company Caszyme at forefront of gene editing

Jim Cornall - November 14, 2023

biotech

Kuano raises £1.8M to accelerate quantum drug discovery

Jim Cornall - September 14, 2023

biotech

Intellegens and CPI receive grant to advance manufacture of oligonucleotide therapeutics with machine learning

Jim Cornall - August 31, 2023

biotech

10 Lithuanian startups to watch

Jim Cornall - July 30, 2023

biotech

Revolutionary self-sensing electric artificial muscles

Jim Cornall - July 18, 2023

1...707172 Page 71 of 72

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 56: GRIN genes and relapsing MS

Jim Cornall - April 24, 2026 0

This week, our conversations are with Bruce Leuchter, co-founder, president, CEO of Neurvati Neurosciences and GRIN Therapeutics; and Daniel Vitt, CEO of Immunic. Base to...

Positive first-in-human data for IVF-related embryo implantation failure treatment

biotech Jim Cornall - April 23, 2026 0

New company plans to replace daily injections with implant

biotech Jim Cornall - April 23, 2026 0

UCB adds epilepsy drug through Neurona Therapeutics acquisition

biotech Jim Cornall - April 23, 2026 0

Mechanism ‘opens new era’ for targeted cancer therapy

biotech Jim Cornall - April 22, 2026 0